By now, the plot is familiar: A mysterious virus appears. The disease, spread by mosquitoes, is linked to an alarming surge in birth defects. There is no vaccine or treatment. The world has been watching this nightmare unfold in countries such as Brazil, where the Zika virus is suspected of causing birth defects and other neurological disorders. Now, in Ontario, another viral outbreak is being linked to a surge in newborn deformities, albeit in a different population: sheep. The little-known Cache Valley virus has long circulated in Canada but veterinarians are alarmed by what they say is the largest outbreak in recent memory.
More ancient viruses may lurk in our DNA than scientists first expected. The new findings may tell researchers a bit more about the viruses that affected our ancient ancestors.
Mass worldwide vaccination with oral polio vaccine (OPV) has resulted in a steep decrease in polio infections and associated paralysis. Since the world is now close to eradicating polio, vaccine-derived polio constitutes an increasing proportion of overall polio infections. From this perspective, introduction of the more expensive inactivated polio vaccine (IPV) solves a problem as emphasised in the Comment by Kimberley Thompson.1 Passive reporting of adverse events in sequential cohorts could show whether any suspected side-effects suddenly increase with a change in vaccine use. However, it does not provide an overall assessment of whether the vaccine actually benefits the health of children. Studies from Guinea-Bissau have shown important beneficial effects of the OPV on child health: mortality was 32% (95% CI 0–55; HR 0·68 [95% CI 0·45–1·00]) lower among neonates randomly assigned to both OPV and BCG than among those randomly assigned to BCG only.2 Observational studies also support the beneficial non-specific effects of OPV on child mortality, reducing mortality by far more than can be explained by preventing polio infections alone.
The only intervention available for Zika virus is mosquito control, which, for Aedes spp mosquitoes, is notoriously difficult to sustain. The full range of mosquito vectors for Zika virus is not yet clear. Growing resistance to insecticides is an important issue, and breeding site destruction and the prevention of bites might be better ways forward. Unlike Ebola virus, for which there were vaccines on the shelf awaiting clinical evaluation, for Zika virus the cupboard is bare—although investigators are working hard to fill it. Understanding the range of neurological disease in Zika virus infection is important not just for the individuals affected, but also to support policy decisions. Experience with Japanese encephalitis in Asia has shown that development of a vaccine is not enough: policy makers need to understand the burden of disease to help to guide vaccine implementation.11 This development and implementation will be some years off. For now there is an urgent priority to understand the scale and full range of neurological disease associated with Zika virus infection.
If the rise of zombies in popular culture has got you wondering if a zombie apocalypse is just over the horizon, put your shotgun down - a University of Queensland expert has confirmed a zombie virus is scientifically and physiologically impossible. Associate Professor Ian M Mackay is affiliated with UQ and specialises in finding and characterising viruses. He said, scientifically speaking, a zombie virus similar to that depicted in popular culture just wouldn’t work.
In light of recent developments, Expert Review of Vaccines is publishing a special issue on dengue vaccines, covering the immunology of dengue pertinent to dengue vaccine development, to a review of the current three leading dengue vaccine candidates (Sanofi Pasteur, Takeda, and NIH/NIAID) and potential new approaches such as sub-unit dengue vaccines, as well as tackling issues related to dengue vaccine introduction communication and advocacy, financing and economics, and various other points for consideration.
The Ministry of Health has set up a multi-sectorial national taskforce to coordinate all efforts to control and manage the outbreak of Rift Valley fever in Kabale district.
The task force is comprised of officials from the Ministry of Health, Agriculture, Water and Environment and Uganda Wildlife Authority-UWA. It is supported by the World Health Organization (WHO) and Centre for Disease Control (CDC).
The development follows the confirmation of an outbreak of Rift Valley fever, a viral infection that primarily affects animals but also has the capacity to infect humans. Up to 5 cases have so far been confirmed in Kabale district over the last 3 days.
The virus, characterized by fever, severe illness and abortions, is transmitted to humans through the handling of animal tissue during slaughtering, conducting veterinary procedures or from the disposal of carcasses or fetuses, according to the WHO. The majority of human infections result from contact with blood or organs of infected animals and persons.
Dr Ruth Aceng, the Director General Health Services, says the task force will conduct research, surveillance training of health workers in case management and conduct social mobilization on mechanism to contain the virus.
Aceng adds that 3 more people have been reported to have signs of the disease, bringing the number to 5 since it was reported 4 days ago.
Dr Nicholas Kawuta, the Director of Animal Resources at the Ministry of Agriculture, says the Rift Valley fever outbreak had been expected at the onset of El Niño rains. He however adds that the government has started working with the World Bank to vaccinate animals in Kabale and surrounding districts.
Although there are clearly objective signs of persistent neurological sequelae in some patients (how many is not quantified in the post), it is notable that the commonest reported symptoms (in a majority of patients) have significant overlap with those associated with post-traumatic stress disorder [PTSD]. It would be of great value if a specific study investigating the prevalence of PTSD could be undertaken. Such symptoms and signs as insomnia, anxiety, hypervigilance, avoidance, nightmares and Impact of Events Scale (IES) might help to clarify whether some of the reported neurological symptoms may in fact be those of PTSD. Reports of a prevalence of PTSD up to at least 25% for survivors of an ICU admission or critical illness have been reported. See: http://hopkinsmedicine.org/news/media/releases/ptsd_common_in_icu_survivors.
Monthly vaginal ring is safe and protects women from HIV - results from two large scale trials among women in Africa. By CCTV Correspondent René Del Carme
n Bangladesh in recent years, there have been repeated mini-outbreaks of a disease called Nipah virus – three people here, four there.
Some people develop no symptoms. But in others, the virus can progress from a fever to fatal brain inflammation within a week.
A few years ago, epidemiologists figured out that people were likely getting Nipah from drinking raw date palm sap, a sweet drink popular in the winter, when the sap is easy to tap from trees pierced with a spigot.
i A bat clings to a palm tree as it eats sap just above a collection jar. Courtesy of Emily Gurley Bats also like the sap and were caught on infrared camera licking streams of it dripping into collection pots. "So you get bat saliva into the stream," says Dr. Stephen Luby, an epidemiologist at Stanford University who worked on solving this initial mystery few years ago. If the bats were shedding virus in their saliva, then a person could get the virus from drinking contaminated raw sap. "We also have some pretty dramatic photos of bats peeing into the date palm sap jars," says Luby, another possible contamination route.
Since AAV2 clonal insertions were observed in a rare subtype of HCC, that is, tumors developed in normal liver without known etiology, it is clearly a rare mechanism of carcinogenesis contrasting with the high frequency of AAV infection. However, a high prevalence of infection in the general population associated with a low incidence of specific cancer is a common observation in infections with oncogenic virus.13 Epstein–Barr virus (EBV), the first proven associated virus to cancer, demonstrates a seroprevalence among adults higher than 80% in most populations. Its relation with lymphoma occurrence was identified epidemiologically and demonstrated with the identification of the EBV viral proteins in a large number of different subtypes of lymphoma.14 For Merkel cell polyomavirus infection, seroprevalence is ranging from 40% to 80% in the general population, and its relation with Merkel cell carcinoma, a very rare but aggressive skin malignancy, was identified with Merkel cell polyomavirus DNA insertion occurring in 80% of the tumors.15 Also, as stated by Moore and Chang, “Another difficulty to understanding viruses in human cancer has been the slow realization that virus infection alone is never sufficient for tumorigenesis, an unsurprising fact that is also true for non-neoplastic viral diseases.”13 Accordingly, other alterations that could cooperate with AAV2 insertion in HCC development remain to be identified.
Measurement of the global burden of malaria is difficult, because many deaths from malaria occur outside the health-care system and other infections might be misdiagnosed as malaria unless a diagnostic test is done. However, there is general agreement that a substantial reduction in both deaths from malaria and cases has occurred during the past decade.1, 2 WHO estimates that between 2000 and 2015, the annual incidence of malaria cases fell by 37% and that the malaria mortality rate fell by 60%.3 These reductions have been achieved largely through scale-up of insecticide-treated bednets and provision of prompt access to effective treatment. Can even better results be obtained from more of the same? WHO estimated that in 2015, about 68% of individuals at risk from malaria slept under an insecticide-treated bednet; this is probably a generous estimate, which might not account for intermittent use of nets, and additionally only few cases received treatment with artemisinin combination therapy. Thus, further scale-up of these interventions is needed.
In a tiny patch of tall trees and tangled undergrowth near the shores of Lake Victoria in Uganda, Zika-carrying mosquitoes buzz around local people who are unperturbed by the global health emergency that the virus has triggered.
I really do think Zika will not be as much a problem in Africa as it is in S America, even if teh "Brazilian" strain gets here: it'll be competing for space in a crowded nanoecology with native Zika, dengue, WNV - and if local mosquitoes don't behave the same way, transmission will be less. If the Brazilian vector gets here - it may well be outcompeted by local varieties of A aegyptii.
Introduction Reports of high rates of primary microcephaly and Guillain–Barré syndrome associated with Zika virus infection in French Polynesia and Brazil have raised concerns that the virus circulating in these regions is a rapidly developing neuropathic, teratogenic, emerging infectious public health threat. There are no licensed medical countermeasures (vaccines, therapies or preventive drugs) available for Zika virus infection and disease. The Pan American Health Organization (PAHO) predicts that Zika virus will continue to spread and eventually reach all countries and territories in the Americas with endemic Aedes mosquitoes. This paper reviews the status of the Zika virus outbreak, including medical countermeasure options, with a focus on how the epidemiology, insect vectors, neuropathology, virology and immunology inform options and strategies available for medical countermeasure development and deployment. Methods Multiple information sources were employed to support the review. These included publically available literature, patents, official communications, English and Lusophone lay press. Online surveys were distributed to physicians in the US, Mexico and Argentina and responses analyzed. Computational epitope analysis as well as infectious disease outbreak modeling and forecasting were implemented. Field observations in Brazil were compiled and interviews conducted with public health officials.
More than 130 people are suspected to have died from a Lassa fever outbreak in Nigeria, according to statistics from the Nigeria Centre for Disease Control (NCDC).
The disease can cause fever and haemorrhaging of various parts of the body -- including the eyes and nose -- and can spread through contact with an infected rat. Person to person transmission is also possible, albeit less common.
For people witnessing the symptoms, alarm bells may ring and raise fears of Ebola -- but this is not Ebola.
West Africa as a region is seeing a flare-up of the disease, but Nigeria -- where Lassa fever was first discovered in 1969 -- is experiencing much higher mortality rates than usual.
On average, Lassa fever is deadly in 1 percent of all individuals infected, with higher rates of 15 percent morbidity among people hospitalized for the illness, but the current outbreak in Nigeria has seen more than 50 percent of those affected dying from their infection.
The current outbreak of Zika virus poses a threat of unknown magnitude to human health. While the range of the virus has been cataloged growing slowly over the last 50 years, the recent explosive expansion in the Americas indicates that the full potential distribution of Zika remains uncertain. Moreover, most current epidemiology relies on its similarities to dengue fever, a phylogenetically closely related disease of unknown similarity in spatial range or ecological niche. Here we compile the first spatially explicit global occurrence dataset from Zika viral surveillance and serological surveys, and construct ecological niche models to test basic hypotheses about its spread and potential establishment. The hypothesis that the outbreak of cases in Mexico and North America are anomalous and outside the ecological niche of the disease, and may be linked to El Nino or similar climatic events, remains plausible at this time. Comparison of the Zika niche against the known distribution of dengue fever suggests that Zika is more constrained by the seasonality of precipitation and diurnal temperature fluctuations, likely confining the disease to the tropics outside of pandemic scenarios. Projecting the range of the diseases in conjunction with vector species (Aedes africanus, Ae. aegypti, and Ae. albopictus) that transmit the pathogens, under climate change, suggests that Zika has potential for northward expansion; but, based on current knowledge, Zika is unlikely to fill the full range its vectors occupy. With recent sexual transmission of the virus known to have occurred in the United States, we caution that our results only apply to the vector-borne aspect of the disease, and while the threat of a mosquito-carried Zika pandemic may be overstated in the media, other transmission modes of the virus may emerge and facilitate naturalization worldwide.
Drosophila melanogaster is an important laboratory model for studies of antiviral immunity in invertebrates, and Drosophila species provide a valuable system to study virus host range and host switching. Here we use metagenomic RNA sequencing of ca. 1400 adult flies to discover 25 new RNA viruses associated with six different drosophilid hosts in the wild. We also provide a comprehensive listing of viruses previously reported from the Drosophilidae. The new viruses include Iflaviruses, Rhabdoviruses, Nodaviruses, and Reoviruses, and members of unclassified lineages distantly related to Negeviruses, Sobemoviruses and Poleroviruses, Flaviviridae, and Tombusviridae. Among these are close relatives of Drosophila X virus and Flock House Virus, which we find in association with wild Drosophila immigrans. These two viruses are widely used in experimental studies, but have not been reported to naturally infect Drosophila. Although we detect no new DNA viruses, in D. immigrans and D. obscura we identify sequences almost identical to Armadillidium vulgare Iridescent Virus (Invertebrate Iridescent Virus 31), bringing the total number of DNA viruses found in the Drosophilidae to three
A multisectoral commission that worked in southern Huila province to assess the situation of yellow fever has identified after screening, the vector of the disease, _Aedes aegypti_, 3 months after the 1st case broke out in the municipality of Caluquembe.
According to the provincial director of health, Altino Matias, so far 60 suspected cases of the disease have been recorded.
However, after identifying the vector of the disease in Lubango city, there is a need to intensify preventive measures.
Yellow fever is a serious infectious disease caused by a virus and transmitted by vectors.
The 1st symptoms of the disease are sudden high fever, chills, fatigue, headache, muscle pain, nausea and vomiting for about 3 days.
The most severe form of the disease is rare and usually appears after a brief wellness period (up to 2 days) may occur when there is liver and kidney failure, jaundice (yellowing of the eyes and skin), bleeding manifestations and severe tiredness.
A patient infected with the Lassa fever virus has been admitted to the special isolation unit of the Frankfurt University Hospital. The individual works at a funeral home in Alzey (Rheinland-Pfalz). He had contact with the body of an individual who died in the Cologne University Hospital at the end of February 2016. The deceased had been in contact with Lassa patients in Togo according to the county government Alzey-Worms.
After the Lassa virus was detected in the blood of the funeral employee, he was admitted to the Frankfurt University Hospital immediately: "It would be the 1st case of Lassa virus infection acquired in German," [see comment below] said virologist Jonas Schmidt-Chanasit of the Bernhard Nocht Institute for Tropical Medicine in Hamburg.
Lassa fever is known as one of the hemorrhagic fevers, such as Ebola and dengue haemorrhagic fevers. The pathogen can cause fever, headache, muscle pain, ecchymosis, and later, diarrhea and vomiting. In severe cases, it can lead to a state of shock, which can lead to organ failure.
According to the Robert Koch Institute, the infection is often mild or without symptoms. According to estimates, 100 000 to 300 000 people are infected each year with the virus, of which one or 2 percent die from the illness. There are no vaccinations to prevent the disease.
In Germany, 6 imported cases have been reported since 1974. The most recent was a US citizen who died on [26 Feb 2016] in Cologne, who had worked in Togo as a nurse. Only several days after his death was the Lassa virus infection detected.
To get content containing either thought or leadership enter:
To get content containing both thought and leadership enter:
To get content containing the expression thought leadership enter:
You can enter several keywords and you can refine them whenever you want. Our suggestion engine uses more signals but entering a few keywords here will rapidly give you great content to curate.